Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs).

Naunyn-Schmiedeberg's archives of pharmacology

A multi-functional oral small molecule targeting energy and lipid metabolism to treat obesity and related metabolic disorders.

Science advances

GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study.

Inflammatory bowel diseases

Glucagon-like receptor-1 agonists and impotence: A meta-analysis.

World journal of methodology

GLP-1 and dual GIP/GLP-1 receptor agonists' psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation.

Current psychiatry reports

Not Just for Diabetes: The Next Frontier for GLP-1 Agonists.

Journal of the American Board of Family Medicine : JABFM

Cognitive signs and symptoms in people with a psychiatric diagnosis on semaglutide: a retrospective cohort study of 13 007 patients in the USA.

BMJ mental health

Trends in utilization of glucagon-like peptide‑1 receptor agonists, sodium-glucose cotransporter‑2 inhibitors, and metabolic bariatric surgery in U.S. Adults with diabetes and obesity.

Diabetes research and clinical practice

$HIMS is still trading at 2.9x PS After falling 78% to $14, the thesis looked very different The recovery was driven by: • Novo agreement, removing the legal overhang • Branded GLP-1 demand proving stronger than feared • Eucalyptus expanding the international opportunity https://t.co/wVJezuDRlk

There's a BPC-157 study record on https://t.co/6CZUfBJKVQ listed as recruiting, finishing 2028. It'll get passed around as proof the peptide is finally being tested properly. Check the sponsor first. ━━━━━━━━━━ Hudson Biotech has eight registrations. All list

"Can I draw my BPC-157 and my TB-500 into the same pin?" comes up every single day in the peptide groups. The answer is mostly yes, with a specific short list of exceptions. The governing variable is time, not chemistry. Most peptide degradation in solution happens over hours

Precisely why I have now partnered with a company that provides Doctor prescribed, 503a pharmacy compounded peptides along with tele-health consultations, blood testing etc. There is a large swath of the population in the US that wants to use peptides to improve their health https://t.co/1R0IyDOVo7

Featured Peptide Products: Tirzepatide Retatrutide Linaclotide Semaglutide GHK-Cu (Copper Peptide) Eptifibatide BPC-157 TB-500 Tesamorelin CJC-1295 In stock and ready to ship! Please contact Just send a dm. CoA available too

( $HIMS) — The Peptide Thread : Everyone’s arguing about whether ($HIMS) is a GLP-1 story. Wrong debate. 1/ The GLP-1 business was the customer acquisition engine. Peptides are what it was acquiring customers for. Here’s the setup, the TAM, and why the infra HIMS quietly https://t.co/8SaqJRn7PO

$VKTX (Viking Therapeutics) is up around 7.76% today to ~$35.93 — its best single-day move in weeks — as the Moderna/Merck Phase 3 mRNA cancer vaccine win lifts the entire metabolic and innovative biotech space, the VANQUISH-1 Phase 3 trial of subcutaneous VK2735 is fully

RT @Frank_Meds: Featured Peptide Products: Tirzepatide Retatrutide Linaclotide Semaglutide GHK-Cu (Copper Peptide) Eptifibatide BPC-157 TB…